Major players in the pharmaceutical industry have formed a coalition to enhance drug manufacturing technologies and reduce production costs.

A newly proposed regulatory framework aims to expedite the approval process for innovative biotech products.

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation

Pfizer announces the opening of a state-of-the-art manufacturing facility dedicated to mRNA technology, enhancing production efficiency and innovation in vaccine development.

Biogen has signed a strategic agreement with a leading contract research organization to expedite its clinical trial processes across multiple drug candidates.

A leading pharmaceutical giant has announced the opening of its latest advanced manufacturing facility in Europe to enhance production capabilities.

A new initiative has been launched to strengthen the pharmaceutical supply chain and address critical drug shortages.

Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Best-in-Class PTRS, today announced results from the landmark myCare-040 clinical study, which demonstrates the predictive capability of the Cellworks

PharmaCo has unveiled a substantial investment in a new biotechnology research facility aimed at accelerating drug development.

The FDA has released new guidelines aimed at enhancing the compliance standards for pharmaceutical packaging.